Chapter 3 Drug Delivery Devices Structure of Human Skin
- Epidermis
- Dermis
- Hypodermis
- Overview of Drug Delivery Systems and Technologies
- Needle-free Devices
- Drug Delivery, by Technology
- Sustained Release Drug Delivery
- Prodrug
- Implants and Intrauterine Devices
- Targeted Drug Delivery
- Polymeric Drug Delivery
- Drug Delivery Systems, by Route of Administration
- Oral Drug Delivery
- Injectable or Parental Drug Delivery
- Pulmonary Drug Delivery
- Nasal Drug Delivery
- Oral Mucosal Drug Delivery
- Rectal Drug Delivery
- Ocular Drug Delivery
- Transdermal Drug Delivery
- Need for Better Methods of Drug Delivery
- Areas of Ongoing Research
Chapter 4 Needle-free Technology and Drug Delivery Devices
- Needle-free Drug Delivery Devices and Types
- History of Needle-free Devices
- Demand for Needle-free Devices
- Advantages of Needle-free Technology
Chapter 5 Needle-free Device Market Dynamics
- Market Drivers
- Increasing Incidence of Needlestick Injuries
- Growing Cases of Needle Phobia
- Increasing Demand for Painless Drug Delivery
- Product Innovations
- Increased Prevalence of Diabetes Globally
- Increasing Incidence of Blood-Borne Diseases Globally
- Growing Cases of HIV/AIDS
- Market Restraints
- Comparative High Cost of Needle-free Technology
- Alternatives Available for Drug Delivery
- High R&D Investments
- Market Competition
- Short Product Life Cycle
- Competitive Landscape
Chapter 6 Market Breakdown by Product Type
- Introduction
- Needle-free Injectors
- Introduction
- Historical Background
- Clinical Need
- Components
- Mechanism of Action
- Applications
- Unmet Needs
- Future Developments
- Needle-free Injectors Market, by Region
- Needle-free Injectors Types
- Needle-free Injectors, by Medication
- Needle-free Injectors, by Drug Delivery
- Needle-free Injectors, by Source of Power
- Needle-free Injectors, by Usage Type
- Inhaler Technologies
- Pulmonary Drug Delivery
- Advantages and Disadvantages of Inhaler Technologies
- Advances in Pulmonary Drug Delivery
- Future Developments
- Inhaler Technologies Market, by Region
- Type of Inhalers
- Metered Dose Inhalers
- Dry Powder Inhalers
- Transdermal Patch Technologies
- Transdermal Drug Delivery
- Clinical Need
- Historical Background
- Types of Transdermal Patches
- Components
- Benefits of Transdermal Patches Over Other Dosage Forms
- New Innovations in Transdermal Patches
- Clinical Issues of Transdermal Delivery
- Future Developments
- Transdermal Patch Technologies Market, by Region
- Other Novel Technologies
- Microneedles
- Pen Needles
Chapter 7 Market Breakdown by Application
- Application of Needle-free Devices
- Pain Management
- Vaccine Delivery
- Insulin Delivery
- Pediatric Drug Delivery
Chapter 8 Market Breakdown by Region
- Introduction
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- South America
- Middle East and Africa
Chapter 9 Market Strategy
- Market Strategy
- Key Mergers and Acquisitions
- Exclusive Partnership Announced by PharmaJet and Mundipharma
- Aequus and Corium Jointly Collaborate for Transdermal Patches
- United Therapeutics Corp. Entered into Licensing Agreement
- Takeda Pharmaceutical Company and Portal Instruments Entered into Collaboration
- Medherant Signed an Agreement with a Japanese Company
- 3M Drug Delivery System Announced Collaboration with Panacea Pharmaceutical
- Cipla and MannKind Corp. Entered into Collaboration
- Increasing Adoption of Home Healthcare Concept
- Key Product and Technology Developments
- Hind Syringes Developed Disposable Pen Needle
- BD Introduced New Pen Needle
- Development of Innovative Transdermal Patch Technology
- Introduction of Smart Inhalers
- Vaxxas' Nanopatch Garners WHO Support for Polio Vaccine Delivery
Chapter 10 Marketed and Pipeline Products
- Key Marketed Products
- Needle-free Injectors
- Inhalers
- Transdermal Patch
- Other Novel Needle Technologies
- Pipeline Products
- Needle-free Injectors
- Metered Dose Inhalers
- Transdermal Patches
Chapter 11 Regulatory Structure
- Regional Regulatory Structures
- United States
- European Union
- Japan
- China
- Hong Kong
- Korea
- Taiwan
- India
- FDA Technical Considerations
- FDA Recall and Safety Alerts
- Occupational Health and Safety Laws
Chapter 12 Reimbursement and Pricing
- Regional Reimbursement Structure
- United States
- Europe
- Japan
- Rest of Asia-Pacific
- Pricing Trends
Chapter 13 Conclusions and Outlook for Needle-free Devices
- Major Market Influencers
- Social Factors
- Technological Developments
- Demographic and Economic Trends
- Transformations in the Healthcare Industry
- Future Outlook
Chapter 14 Company Profiles
- 3M
- Activa Brand Products, Inc.
- Akra Dermojet
- Alkermes Plc
- Amnio Technology Llc.
- Antares Pharma, Inc.
- Aradigm Corp.
- Astellas Pharma, Inc.
- Astrazeneca Plc
- Battelle
- Bespak Europe Ltd.
- Bioject Medical Technologies
- Bristol-Myers Squibb
- Clearside Biomedical, Inc.
- Corium International, Inc.
- Crossject
- Captisol
- D'antonio Consultants International
- Duoject Medical Systems, Inc.
- Durect Corp.
- Echo Therapeutics
- Endo International
- Ferndale Pharma Group, Inc.
- Ferring Pharmaceuticals, Inc.
- Gerresheimer Ag
- Glaxosmithkline Plc
- Glide Pharmaceutical Technologies Ltd.
- Haselmeier Gmbh
- Injex Pharma Ag
- JCR Pharmaceuticals Co. Ltd.
- Keystone Industries
- Lineage Therapeutics, Inc.
- Lohmann Therapie-Systeme Ag
- Medical International Technologies
- Medtronic
- Merck Serono S.A.
- Minnesota Rubber & Plastics
- Mylan, Inc.
- Nanopass Technologies Ltd.
- National Medical Products, Inc.
- Novartis
- Noven Pharmaceuticals
- Novo Nordisk A/S
- Nypro, Inc.
- Penjet Corp.
- Syneron Medical Ltd.
- Team Consulting Ltd.
- Teva Pharmaceuticals Industries Ltd.
- Theraject, Inc.
- Valeritas, Inc.
- Vaxxas Pty Ltd.
- Ypsomed Ag
- Zogenix, Inc.
List of Tables
Summary Table: Global Market for Needle-free Devices, by Product Type, Through 2023
Table 1: Prodrugs and their Active Metabolites
Table 2: Advantages and Disadvantages of Oral Drug Delivery
Table 3: Advantages and Disadvantages of Injectable Drug Delivery
Table 4: Advantages and Disadvantages of Pulmonary Drug Delivery
Table 5: Advantages and Disadvantages of Nasal Drug Delivery
Table 6: Advantages and Disadvantages of Oral Mucosal Drug Delivery
Table 7: Advantages and Disadvantages of Rectal Drug Delivery
Table 8: Advantages and Disadvantages of Ocular Drug Delivery
Table 9: Advantages and Disadvantages of Transdermal Drug Delivery
Table 10: Global HIV-Infected People and New Cases, by Region, 2016
Table 11: Global Needle-free Device Market Vendors, by Ranking, 2017
Table 12: Global Market for Needle-free Devices, by Product Type, Through 2023
Table 13: Advantages and Disadvantages of Needle-free Injectors
Table 14: Global Market for Needle-free Injectors, by Region, Through 2023
Table 15: Global Market for Needle-free Injectors, by Medication, Through 2023
Table 16: Global Market for Needle-free Injectors, by Drug Delivery, Through 2023
Table 17: Ideal Characteristics of Therapeutic Aerosols
Table 18: Advantages and Disadvantages of Pulmonary Drug Delivery
Table 19: Advantages and Disadvantages of Inhaler Technologies
Table 20: Asthma Prevalence, by Country, 2016-2018
Table 21: Global Market for Inhaler Technologies, by Region, Through 2023
Table 22: Advantages and Disadvantages of Metered Dose Inhalers
Table 23: Advantages and Disadvantages of Standard Press and Breath MDIs
Table 24: Advantages and Disadvantages of Dry Powder Inhalers
Table 25: Global Market for Inhaler Technologies, by Type, Through 2023
Table 26: Ideal Properties of Transdermal Drug Delivery Systems
Table 27: Parameters Affecting Selection of Drugs in Transdermal Drug Delivery Systems
Table 28: Advantages and Disadvantages of Transdermal Patches
Table 29: Global Market for Transdermal Patch Technologies, by Region, Through 2023
Table 30: Global Market for Other Novel Technologies, by Region, Through 2023
Table 31: Advantages and Disadvantages of Microneedle Technologies
Table 32: Advantages and Disadvantages of Pen Needles
Table 33: Top 10 Countries with High Percentage of Diabetic Population, 2017
Table 34: Comparison Between Painful and Painless Needle-free Insulin Drug Delivery Systems
Table 35: Global Market for Needle-free Devices, by Region, Through 2023
Table 36: United States Market for Needle-free Devices, by Product Segment, Through 2023
Table 37: Canadian Market for Needle-free Devices, by Product Segment, Through 2023
Table 38: Mexican Market for Needle-free Devices, by Product Segment, Through 2023
Table 39: European Market for Needle-free Devices, by Product Segment, Through 2023
Table 40: German Market for Needle-free Devices, by Product Segment, Through 2023
Table 41: U.K. Market for Needle-free Devices, by Product Segment, Through 2023
Table 42: French Market for Needle-free Devices, by Product Segment, Through 2023
Table 43: Italian Market for Needle-free Devices, by Product Segment, Through 2023
Table 44: Spanish Market for Needle-free Devices, by Product Segment, Through 2023
Table 45: Asia-Pacific Market for Needle-free Devices, by Product Segment, Through 2023
Table 46: Chinese Market for Needle-free Devices, by Product Segment, Through 2023
Table 47: Indian Market for Needle-free Devices, by Product Segment, Through 2023
Table 48: Japanese Market for Needle-free Devices, by Product Segment, Through 2023
Table 49: South Korean Market for Needle-free Devices, by Product Segment, Through 2023
Table 50: Rest of Asia-Pacific Market for Needle-free Devices, by Product Segment, Through 2023
Table 51: South American Market for Needle-free Devices, by Product Segment, Through 2023
Table 52: HIV Acquisition in the Middle East and North Africa, by Mode, 2014
Table 53: Middle Eastern and African Market for Needle-free Devices, by Product Segment, Through 2023
Table 54: Key Metered Dose Inhalers in the Market
Table 55: Transdermal Patches: Key Marketed Products
Table 56: Other Novel Technologies: Marketed Products
Table 57: Key Metered Dose Inhalers: Pipeline Products
Table 58: Transdermal Patches: Pipeline Products
Table 59: Differences in Regulatory Approvals in the United States and Europe
Table 60: 3M: Net Revenue, 2015-2017
Table 61: 3M: Marketed Products, 2017
Table 62: Akra Dermojet Brand Products: Marketed Products, 2017
Table 63: Antares Pharma, Inc.: Marketed Products, 2017
Table 64: Aradigm Corp.: Marketed Products, 2017
Table 65: AstraZeneca Plc: Net Revenue, 2015-2017
Table 66: Medtronic: Net Revenue, 2015-2017
Table 67: Novartis: Net Revenue, 2017
Table 68: Teva Pharmaceuticals Industries Ltd.: Net Revenue, 2015-2017
Table 69: Abbreviations Used in Needle-free Devices and Technologies
List of Figures
Summary Figure: Global Market for Needle-free Devices, by Product Type, 2017-2023
Figure 1: Diabetes Prevalence, by Region, 2015
Figure 2: Global Market for Needle-free Devices, by Product Type, 2017-2023
Figure 3: Global Market for Needle-free Injectors, by Region, 2017-2023
Figure 4: Global Market for Needle-free Injectors, by Medication, 2017-2023
Figure 5: Global Market for Needle-free Injectors, by Drug Delivery, 2017-2023
Figure 6: Global Market for Inhaler Technologies, by Region, 2017-2023
Figure 7: Global Market for Inhaler Technologies, by Type, 2017-2023
Figure 8: Global Market for Transdermal Patch Technologies, by Region, 2017-2023
Figure 9: Global Market for Other Novel Technologies, by Region, 2017-2023
Figure 10: Global Market Share for Needle-free Devices, by Application, 2017
Figure 11: Global Market for Needle-free Devices, by Region, 2017-2023
Figure 12: Prevalence of Diabetes in North America, by Country, 2017
Figure 13: United States Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 14: Canadian Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 15: Mexican Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 16: Prevalence of Diabetes in Europe, by Country, 2017
Figure 17: European Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 18: German Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 19: U.K. Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 20: French Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 21: Italian Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 22: Spanish Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 23: Prevalence of Diabetes in Asia-Pacific, by Country, 2017
Figure 24: Asia-Pacific Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 25: Chinese Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 26: Indian Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 27: Japanese Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 28: South Korean Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 29: Rest of Asia-Pacific Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 30: South American Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 31: Middle Eastern and African Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 32: Diabetes Prevalence in Africa, 2017
Figure 33: Diabetes Prevalence in Middle East and Pakistan, 2017
Figure 34: Diabetes Prevalence in South and Central America, 2017
Figure 35: Diabetes Prevalence in South-East Asia, 2017
Figure 36: Diabetes Prevalence in North America and Caribbean, 2017
Figure 37: Diabetes Prevalence in Europe, 2017
Figure 38: 3M: Net Revenue, by Healthcare Segment, 2015-2017
